- Home
- MEOH vs RLAY Comparison
MEOH vs RLAY Comparison
Compare MEOH & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MEOH | RLAY |
|---|---|---|
| Founded | 1968 | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.1B |
| IPO Year | 1995 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MEOH | RLAY |
|---|---|---|
| Price | $61.56 | $18.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 13 |
| Target Price | ★ $70.30 | $27.58 |
| AVG Volume (30 Days) | 738.4K | ★ 3.2M |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | ★ 1.19% | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,355,000.00 |
| Revenue This Year | $36.94 | N/A |
| Revenue Next Year | N/A | $60.51 |
| P/E Ratio | $16.44 | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $32.00 | $5.85 |
| 52 Week High | $66.75 | $21.27 |
Technical Indicators
Market Signals| Indicator | MEOH | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 56.81 | 44.74 |
| Support Level | $57.32 | $17.83 |
| Resistance Level | $64.10 | $20.54 |
| Average True Range (ATR) | 1.68 | 0.99 |
| MACD | 0.14 | -0.04 |
| Stochastic Oscillator | 70.19 | 38.21 |
Price Performance
Historical ComparisonAbout MEOH Methanex Corporation
Methanex Corp operates as a producer and supplier of methanol to various international markets in North America, Asia Pacific, Europe and South America. The company's operations consist prominently of the production and sale of methanol, along with the production and sale of ammonia. Geographically, it operates in China, Europe, the United States, South America, South Korea, Other Asia, and Canada. The majority of revenue is derived from Europe.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.